CellaVision is the world-leading provider of digital solutions for medical microscopy in the field of hematology. We have made it our business to help hematology laboratories around the world improve and transform the process of analyzing blood and other body fluids by automated microscopy.
Cellavision was founded by Christer Fahraeus while he was in Medical school working on his PhD in Neurophysiology at the Faculty of Medicine at Lund University. It is one of the first successful AI companies founded in Sweden, and the world leader in its field with a market cap of around 1 billion USD.
The share is listed on the NASDAQ Stockholm main market.
EQL Pharma is an entrepreneurial pharmaceutical company focusing on simplicity and efficiency at all levels of the value chain in order to be able to deliver cost-efficient medicines of highest quality to pharmacies and hospitals, primarily in the Nordic region, but with expansion into rest of Europe.
The company conducts extensive development activities in collaboration with partners in Asia, Europe and India. Our strategy is to develop generic medicines in areas where the competition is limited, so-called niche generics.
EQL Pharma was founded by Christer Fahraeus in 2006 and is listed on the Spotlight Stock Market.
Gasporox supplies the pharmaceutical, food and beverage industry with laser sensors for quality control. Unlike existing methods, Gasporox’s unique technology can meet the packaging industry’s need for automated, complete, non-destructive and cost-effective quality control. The number of packaging with a protective atmosphere is estimated at 500 billion annually in the food industry.
Gasporox is a spin-off from Division of Atomic Physics at Lund University.